These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19332087)

  • 1. Dysport: pharmacological properties and factors that influence toxin action.
    Pickett A
    Toxicon; 2009 Oct; 54(5):683-9. PubMed ID: 19332087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of botulinum neurotoxin type A].
    Bigalke H
    Wien Klin Wochenschr; 2001; 113 Suppl 4():2-5. PubMed ID: 15506044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do different formulations of botulinum toxin type A really have different migration characteristics?
    Karsai S; Raulin C
    J Cosmet Dermatol; 2008 Sep; 7(3):230. PubMed ID: 18789061
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of type a botulinum toxin products in clinical use.
    Pickett A; Caird D
    J Clin Pharm Ther; 2008 Jun; 33(3):327-8. PubMed ID: 18452421
    [No Abstract]   [Full Text] [Related]  

  • 5. Presynaptic neurotoxins with enzymatic activities.
    Rossetto O; Montecucco C
    Handb Exp Pharmacol; 2008; (184):129-70. PubMed ID: 18064414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing two botulinum toxin type A formulations using manufacturers' product summaries.
    Wenzel R; Jones D; Borrego JA
    J Clin Pharm Ther; 2007 Aug; 32(4):387-402. PubMed ID: 17635341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.
    Wohlfarth K; Kampe K; Bigalke H
    Mov Disord; 2004 Mar; 19 Suppl 8():S65-7. PubMed ID: 15027057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A.
    Hexsel D; Dal'Forno T; Hexsel C; Do Prado DZ; Lima MM
    Dermatol Surg; 2008 Jan; 34(1):52-9. PubMed ID: 18053050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study.
    Cliff SH; Judodihardjo H; Eltringham E
    J Cosmet Dermatol; 2008 Mar; 7(1):50-4. PubMed ID: 18254812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
    Wohlfarth K; Sycha T; Ranoux D; Naver H; Caird D
    Curr Med Res Opin; 2009 Jul; 25(7):1573-84. PubMed ID: 19463043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and immunology of botulinum toxin type A.
    Aoki KR
    Clin Dermatol; 2003; 21(6):476-80. PubMed ID: 14759579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A-when is a unit not a unit?
    Harper L
    J Urol; 2009 Jan; 181(1):414; discussion 414-5. PubMed ID: 19019386
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.
    de Almeida AT; De Boulle K
    J Cosmet Laser Ther; 2007; 9 Suppl 1():17-22. PubMed ID: 17885882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeomin is free from complexing proteins.
    Frevert J
    Toxicon; 2009 Oct; 54(5):697-701. PubMed ID: 19292989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic and clinical aspects of BOTOX.
    Brin MF
    Toxicon; 2009 Oct; 54(5):676-82. PubMed ID: 19341758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
    Shah AR
    J Drugs Dermatol; 2008 Sep; 7(9):847-50. PubMed ID: 19112798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A for the treatment of chronic anal fissure.
    Brisinda G; Cadeddu F; Mazzeo P; Maria G
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into clostridial neurotoxin-SNARE interactions.
    Breidenbach MA; Brunger AT
    Trends Mol Med; 2005 Aug; 11(8):377-81. PubMed ID: 16006188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncontrollable distant effects of botulinum neurotoxin injections.
    Schames J; Dov Prero Y; Schames D; Schames M; Gabriel W; Reed R
    J Calif Dent Assoc; 2009 Jan; 37(1):44-5. PubMed ID: 19263628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin type A and cholinergic system].
    Bach-Rojecky L; Relja M; Filipović B; Lacković Z
    Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.